Hsiao, L., Chiou, T., Gau, J., Yang, C., Yu, Y., Liu, C., . . . Huang, Y. (2015). Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study. Medicine (Baltimore).
Citação norma ChicagoHsiao, Liang-Tsai, et al. "Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study." Medicine (Baltimore) 2015.
MLA引文Hsiao, Liang-Tsai, et al. "Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study." Medicine (Baltimore) 2015.
警告：這些引文格式不一定是100％准確.